Extensive clinical trials over the past quarter century have addressed the safety and efficacy of curcumin against numerous diseases in humans. Some promising effects have been observed in patients with various pro-inflammatory diseases including cancer, cardiovascular disease, arthritis, and many more.
Curcumin is known to possess potent anti-inflammatory and anti-arthritic properties. In a recent pilot clinical study published in Phytotherapy Research, evaluated the safety and effectiveness of curcumin alone, and in combination with diclofenac sodium in patients with active rheumatoid arthritis. The patients diagnosed with RA were split into three groups receiving either curcumin (500 mg) and diclofenac sodium (50 mg) alone or their combination. Patients in all three treatment groups showed statistically significant improvement, but the curcumin group showed the highest percentage of improvement. The study provides the first evidence for the safety and superiority of curcumin treatment in patients with active RA.
Scientists have long been aware of the wide array of health benefits from the Indian spice turmeric, which is a source of the active phytochemical curcumin. Until now, curcumin has been known to have poor bioavailability, requiring high doses to promote health. BCM-95® delivers significantly more pharmacologically bioactive curcumin into the blood than other curcumin sources. This new delivery system allows for a variety of health benefits.
There are many curcumin products on the market, but Curcumin Extreme™ with BCM-95® has superior bioavailability and absorption.
If you are taking any prescription drugs or have an ongoing medical condition, you should consult your physician before using this product. Your physician can properly advise you about the best course of action regarding your prescription medications.